Mammalian Animal and Human Retinal Organ Culture as Pre-Clinical Model to Evaluate Oxidative Stress and Antioxidant

Martina Kropp1,2, Mohit Mohit1,2, Cristina Ioana Leroy-Ciocanea3,4

  • 1Experimental Ophthalmology, University of Geneva,1205 Geneva, Switzerland.

Insights

Developing enhanced retinal cultures from human and animal tissues provides a reliable model for studying oxidative stress in diseases like AMD and DR. This method reduces animal use and improves therapeutic testing transferability.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Toxicology

Background:

  • Oxidative stress (OS) is a key factor in retinal neurodegenerative diseases, including age-related macular degeneration (AMD) and diabetic retinopathy (DR).
  • Current in vivo testing of therapeutics faces limitations in transferability and ethical concerns regarding animal use.

Purpose of the Study:

  • To establish and validate an enhanced mammalian and human retina culture model for studying OS-related retinal diseases.
  • To assess the efficacy of antioxidative therapeutics in a controlled in vitro setting, reducing reliance on animal models.

Main Methods:

  • Retinae from bovine, porcine, rat, and human sources were cultured for 3-14 days.
  • Oxidative stress was induced using high glucose or hydrogen peroxide (H₂O₂).
  • Treated samples with scutellarin, pigment epithelium-derived factor (PEDF), and granulocyte macrophage colony-stimulating factor (GM-CSF), assessing tissue morphology, cell viability, inflammation, and glutathione levels.

Main Results:

  • Retina cultures demonstrated moderate necrosis (27.00 ± 1.66 AU PI-staining after 14 days).
  • Successful induction of OS was confirmed by reduced ATP content (288.3 ± 59.9 nM vs. 435.7 ± 166.8 nM in controls).
  • Antioxidants significantly reduced OS-induced apoptosis, with scutellarin treatment decreasing cell apoptosis.

Conclusions:

  • Enhanced retina cultures offer a reliable and highly transferable model for OS research in age-related retinal diseases.
  • This model facilitates pre-clinical testing of antioxidative therapeutics, aligning with ethical considerations and improving translational potential.

Related Concept Videos